$6.17
-0.23 (-3.59%)
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)
CAPS Rating:
The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions.
The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions.